SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Cheng who wrote (949)6/4/1997 7:40:00 PM
From: I. Luttichuys   of 1762
 
Hello Don, Like a posted earlier, I feel this may be a bump and not anything which would prevent the company from "existing for a very long time". I am worried only about CE9.1 and felt that my exposure to IDPH stock and other's exposures whom I had in IDPH stock was too high. My risk tolerance is especially low as it concerns others money.
Also, I posted that I think short term we are still in good shape so, I am maintaining a position in calls after some thought and, if I am right to be somewhat bullish short-term, I will execute the calls and maintain those shares as a long position.
My problem is that I am afraid some explanation for the SmithKline sales might come to light and, I felt I could not be so heavily in IDEC with that uncertainty when I have other stocks coming into play which I feel safer about.
I think at heart, I will always be an IDEC shareholder so don't be surprised to see me use these calls should the July 25 hit the money.
When that bump comes (if it comes) I will deal with it with my new and somewhat attenuated position.
Thanks for the sentiment, Don
The people here really do make it my favourite thread.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext